UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000023140
Receipt No. R000026679
Scientific Title Quality of Systematic Reviews Underlying Clinical Practice Guidelines
Date of disclosure of the study information 2016/08/01
Last modified on 2016/07/13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Quality of Systematic Reviews Underlying Clinical Practice Guidelines
Acronym Quality of Systematic Reviews underlying Clinical Practice Guidelines for Traumatic Brain Injury
Scientific Title Quality of Systematic Reviews Underlying Clinical Practice Guidelines
Scientific Title:Acronym Quality of Systematic Reviews underlying Clinical Practice Guidelines for Traumatic Brain Injury
Region
North America

Condition
Condition Methodological Quality and completeness of reporting as represented by the AMSTAR tool and PRISMA checklist.
Classification by specialty
Medicine in general Neurology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The purpose of this study is to assess the methodological quality and completeness of reporting in Systematic Reviews underlying current Clinical Practice Guidelines for Traumatic Brain Injury across professional organizations both domestic and international.
Basic objectives2 Others
Basic objectives -Others To assess the methodological quality and completeness of reporting in Systematic Reviews underlying Clinical Practice Guidelines for Traumatic Brain Injury.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Global Methodological Quality and Completeness of Reporting of Clinical Practice Guidelines as represented by underlying systematic reviews graded with the AMSTAR tool and PRISMA checklist, respectively.
Key secondary outcomes Proportion of recommendations in CPGs with underlying evidence based on Systematic Reviews vs proportion of recommendations not based on systematic reviews.

Quality of evidence underlying key specific recommendations as represented by methodological quality and completeness of reporting of systematic reviews used for each key recommendation.

Base
Study type Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Clinical Practice Guidelines:
1. Clinical Practice Guidelines must be recognized by a national governmental or provider/professional organization.
2. Clinical Practice Guidelines must be in English.
3. Clinical Practice Guidelines must contain recommendations relevant to best practices in the diagnosis, treatment, and/or management of Traumatic Brain Injury.

Systematic Reviews:
1. Systematic Reviews must be in English.
2. Systematic Reviews must be peer-reviewed and published, or currently in press.
3. The Systematic Review must have performed a systematic search and synthesis of available evidence.
4. The Systematic Review includes, at least in part, a synthesis of data from pediatric populations
Key exclusion criteria Clinical Practice Guidelines:
1. Clinical Practice Guidelines without reference lists and those without readily accessible reference lists such as those only accessible by email correspondence will be excluded.
2. Addendums published relevant to one or more recommendations for a CPG will be excluded.
3. CPGs not recognized by a professional organization or governmental body will be excluded.

Systematic Reviews:
1. Systematic reviews of animal studies will be excluded.
Target sample size 100

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Matt Vassar
Organization Oklahoma State University Center for Health Sciences
Division name College of Osteopathic Medicine
Zip code
Address 1111 W. 17th St.
TEL 918-582-1972
Email matt.vassar@okstate.edu

Public contact
Name of contact person
1st name
Middle name
Last name Matt Vassar
Organization Oklahoma State University Center for Health Sciences
Division name College of Osteopathic Medicine
Zip code
Address 1111 W. 17th St.
TEL 918-582-1972
Homepage URL http://www.healthsciences.okstate.edu
Email matt.vassar@okstate.edu

Sponsor
Institute Oklahoma State University Center for Health Sciences
Institute
Department

Funding Source
Organization Oklahoma State University Center for Health Sciences
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 08 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 07 Month 01 Day
Date of IRB
Anticipated trial start date
2016 Year 07 Month 04 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information No other relevant information

Management information
Registered date
2016 Year 07 Month 13 Day
Last modified on
2016 Year 07 Month 13 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026679

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.